Preoperative assessment of asymptomatic adnexal masses by positron emission tomography and F-18-fluorodeoxyglucose

被引:0
作者
Fenchel, S
Kotzerke, J
Stöhr, I
Grab, D
Nüssle, K
Rieber, A
Kreienberg, R
Brambs, HJ
Reske, SN
机构
[1] Univ Ulm, Abt Nukl Med, D-89069 Ulm, Germany
[2] Univ Ulm, Frauenklin, D-7900 Ulm, Germany
[3] Univ Ulm, Abt Rontgendiagnostik, D-89069 Ulm, Germany
关键词
ovarian tumors; borderline-tumors; F-18-FDG; positron emission tomography;
D O I
暂无
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Aim: To evaluate use of F-18-FDG-PET in assessment of dignity of asymptomatic adnexal masses. Methods: 85 asymptomatic patients with suspicious, asymptomatic adnexal masses were evaluated. Static FDG-PET (Exact HR+ or ECAT 931) imaging of the abdomen was performed following application of 222-555 MBq F-18-FDG. iterative reconstruction was applied. PET data were analysed visually, at first without and second together with MRT images. Final diagnosis was made by histopathology. Results: FDG-PET allowed correct identification of 4 of 8 malignant adnexal rumors. False negative results were obtained in 2 adenocarcinomas stage pT1a and 2 borderline-tumors. In 60 out of 77 benign adnexal masses malignancy could be excluded. False positive FDG-uptake, partly because of misinterpretation of gastrointestinal activity, was found in 3 inflammatory processes, 1 teratoma, 1 benign schwannoma, 1 dermoid cyst, 1 benign thecoma, 1 serous cyst, 1 serous cystadenoma, 2 mucinous cystadenomas, 2 corpus luteum cysts, 3 endometriosic cysts and 1 sactosalpinx. The overall sensitivity and specifity of FDG-PET alone were 50% and 78%. Evaluation together with MRT images showed a sensitivity of 50% and a specifity of 86%. Conclusion: Sensitivity of FDG-PET in detection of borderline-tumors and early stage ovarian cancer seems to be limited. Low incidence of malignant ovarian tumors requires for assesment of dignity a procedure of high specifity, that is not reached by FDG-PET neither without nor together with MRT images for topographic orientation. Therefore use of FDG-PET for assesment of dignity in suspicious, asymptomatic ovarian tumors is limited.
引用
收藏
页码:101 / 107
页数:7
相关论文
共 22 条
[1]  
Bender H, 1997, ANTICANCER RES, V17, P1655
[2]  
Bischof Delaloye A., 1995, Journal of Nuclear Medicine, V36, p106P
[3]   IMAGING IN GYNECOLOGIC MALIGNANCIES [J].
BRAGG, DG ;
HRICAK, H .
CANCER, 1993, 71 (04) :1648-1651
[4]   EXPERIENCE WITH POSITRON EMISSION TOMOGRAPHY (PET) SCANS IN PATIENTS WITH OVARIAN-CANCER [J].
CASEY, MJ ;
GUPTA, NC ;
MUTHS, CK .
GYNECOLOGIC ONCOLOGY, 1994, 53 (03) :331-335
[5]   ASSESSMENT OF PRIMARY AND METASTATIC OVARIAN-CANCER BY POSITRON EMISSION TOMOGRAPHY (PET) USING 2-[F-18]DEOXYGLUCOSE (2-[F-18]FDG) [J].
HUBNER, KF ;
MCDONALD, TW ;
NIETHAMMER, JG ;
SMITH, GT ;
GOULD, HR ;
BUONOCORE, E .
GYNECOLOGIC ONCOLOGY, 1993, 51 (02) :197-204
[6]   WHOLE-BODY POSITRON EMISSION TOMOGRAPHY WITH 2-[F-18]-FLUORO-2-DEOXY-D-GLUCOSE CAN DETECT RECURRENT OVARIAN-CARCINOMA [J].
KARLAN, BY ;
HAWKINS, R ;
HOH, C ;
LEE, M ;
TSE, N ;
CANE, P ;
GLASPY, J .
GYNECOLOGIC ONCOLOGY, 1993, 51 (02) :175-181
[7]   Evaluation of pulmonary lesions with FDG-PET - Comparison of findings in patients with and without a history of prior malignancy [J].
Knight, SB ;
Delbeke, D ;
Stewart, JR ;
Sandler, MP ;
Ebers, T .
CHEST, 1996, 109 (04) :982-988
[8]   PET imaging of primary mediastinal tumours [J].
Kubota, K ;
Yamada, S ;
Kondo, T ;
Yamada, K ;
Fukuda, H ;
Fujiwara, T ;
Ito, M ;
Ido, T .
BRITISH JOURNAL OF CANCER, 1996, 73 (07) :882-886
[9]  
KUBOTA R, 1992, J NUCL MED, V33, P1972
[10]  
Magrina JF, 1997, MAYO CLIN PROC, V72, P653